Sabaa International Company for Pharmaceutical and Chemical Industry - Neraca (Quarterly)

Sabaa International Company for Pharmaceutical and Chemical Industry
EG ˙ CASE
Talaan ng Balanse (Quarterly)

Neraca Sabaa International Company for Pharmaceutical and Chemical Industry menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
12-31
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 6 8 12 13 12 5 0 1 0 1 0 0 0 1 1 2 2
Change (%) 29.88 49.82 10.70 -11.57 -58.85 -95.04 255.28 -82.56 358.99 -38.28 -58.33 158.63 13.47 18.00 184.10 22.03
Assets Current 71 54 64 65 51 48 46 44 47 56 63 63 65 63 62 72 72
Change (%) -23.97 19.74 1.34 -21.66 -5.94 -5.38 -3.60 5.97 20.04 12.33 -0.29 4.39 -3.79 -0.59 15.09 -0.05
Assets 131 150 159 162 160 156 152 155 156 163 170 169 171 169 169 177 176
Change (%) 14.62 5.84 1.60 -0.92 -2.64 -2.28 1.80 0.56 4.49 4.48 -0.54 1.19 -1.26 -0.32 4.96 -0.60
Liabilities 29 40 46 50 46 40 36 38 41 52 55 54 64 65 72 77 67
Change (%) 36.70 16.18 8.05 -7.39 -13.04 -9.91 5.53 6.60 26.84 6.61 -2.70 18.78 2.06 9.95 7.75 -13.18
Equity 102 110 113 112 114 116 116 117 115 111 115 116 107 104 97 100 109
Change (%) 8.28 2.09 -1.06 2.00 1.61 0.39 0.63 -1.43 -3.47 3.48 0.50 -7.02 -3.23 -6.77 2.88 9.17
Liabilities And Stock Equity 131 150 159 162 160 156 152 155 156 163 170 169 171 169 169 177 176
Change (%) 14.62 5.84 1.60 -0.92 -2.64 -2.28 1.80 0.56 4.49 4.48 -0.54 1.19 -1.26 -0.32 4.96 -0.60

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista